Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed study information regarding CTI-1601 and Friedreich Ataxia, while a new revision number has been added.SummaryDifference23%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check96 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check103 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.